argenex (ARGX) Competitors

Sanofi (NASDAQ:SNY) and argenex (NASDAQ:ARGX) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations, media sentiment and dividends.

Do institutionals and insiders believe in SNY or ARGX?

14.0% of Sanofi shares are held by institutional investors. Comparatively, 60.3% of argenex shares are held by institutional investors. 1.0% of Sanofi shares are held by company insiders. Comparatively, 2.4% of argenex shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Do analysts rate SNY or ARGX?

Sanofi presently has a consensus price target of $61.50, suggesting a potential upside of 26.75%. argenex has a consensus price target of $728.06, suggesting a potential upside of 25.98%. Given Sanofi's stronger consensus rating and higher probable upside, equities research analysts clearly believe Sanofi is more favorable than argenex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanofi	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	3 Strong Buy rating(s)	3.11
argenex	0 Sell rating(s)	0 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	3.10

Is SNY or ARGX more profitable?

argenex has a net margin of 40.20% compared to Sanofi's net margin of 14.56%. Sanofi's return on equity of 17.15% beat argenex's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanofi	14.56%	17.15%	9.80%
argenex	40.20%	16.15%	14.33%

Does the media favor SNY or ARGX?

In the previous week, Sanofi had 23 more articles in the media than argenex. MarketBeat recorded 35 mentions for Sanofi and 12 mentions for argenex. argenex's average media sentiment score of 1.21 beat Sanofi's score of 0.73 indicating that argenex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sanofi	13 Very Positive mention(s)	5 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
argenex	6 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher valuation and earnings, SNY or ARGX?

Sanofi has higher revenue and earnings than argenex. Sanofi is trading at a lower price-to-earnings ratio than argenex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanofi	$45.17B	2.63	$6.02B	$2.80	17.33
argenex	$2.25B	15.71	$833.04M	$16.21	35.65

Which has more volatility and risk, SNY or ARGX?

Sanofi has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500. Comparatively, argenex has a beta of 0.37, suggesting that its share price is 63% less volatile than the S&P 500.

Summary

argenex beats Sanofi on 9 of the 17 factors compared between the two stocks.